Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104177331A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Bilastine avoids toxic reagents. High yield, cost-effective manufacturing for pharmaceutical supply chains.
Novel patent CN104177331A offers high-purity Bilastine intermediate synthesis with reduced toxicity and improved yield for pharmaceutical manufacturing.